Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

15 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Defining brain volume cutoffs to identify clinically relevant atrophy in RRMS.
Sormani MP, Kappos L, Radue EW, Cohen J, Barkhof F, Sprenger T, Piani Meier D, Häring D, Tomic D, De Stefano N. Sormani MP, et al. Among authors: piani meier d. Mult Scler. 2017 Apr;23(5):656-664. doi: 10.1177/1352458516659550. Epub 2016 Jul 18. Mult Scler. 2017. PMID: 27411701
Predicting risk of secondary progression in multiple sclerosis: A nomogram.
Manouchehrinia A, Zhu F, Piani-Meier D, Lange M, Silva DG, Carruthers R, Glaser A, Kingwell E, Tremlett H, Hillert J. Manouchehrinia A, et al. Among authors: piani meier d. Mult Scler. 2019 Jul;25(8):1102-1112. doi: 10.1177/1352458518783667. Epub 2018 Jun 18. Mult Scler. 2019. PMID: 29911467
Learning ability correlates with brain atrophy and disability progression in RRMS.
Sormani MP, De Stefano N, Giovannoni G, Langdon D, Piani-Meier D, Haering DA, Kappos L, Tomic D. Sormani MP, et al. Among authors: piani meier d. J Neurol Neurosurg Psychiatry. 2019 Jan;90(1):38-43. doi: 10.1136/jnnp-2018-319129. Epub 2018 Oct 15. J Neurol Neurosurg Psychiatry. 2019. PMID: 30322898 Free PMC article.
A mixed methods approach towards understanding key disease characteristics associated with the progression from RRMS to SPMS: Physicians' and patients' views.
Ziemssen T, Tolley C, Bennett B, Kilgariff S, Jones E, Pike J, Tomic D, Piani-Meier D, Lahoz R. Ziemssen T, et al. Among authors: piani meier d. Mult Scler Relat Disord. 2020 Feb;38:101861. doi: 10.1016/j.msard.2019.101861. Epub 2019 Nov 18. Mult Scler Relat Disord. 2020. PMID: 31865132 Free article.
Siponimod: Disentangling disability and relapses in secondary progressive multiple sclerosis.
Cree BA, Magnusson B, Rouyrre N, Fox RJ, Giovannoni G, Vermersch P, Bar-Or A, Gold R, Piani Meier D, Karlsson G, Tomic D, Wolf C, Dahlke F, Kappos L. Cree BA, et al. Among authors: piani meier d. Mult Scler. 2021 Sep;27(10):1564-1576. doi: 10.1177/1352458520971819. Epub 2020 Nov 18. Mult Scler. 2021. PMID: 33205682 Free PMC article. Clinical Trial.
Effect of siponimod on magnetic resonance imaging measures of neurodegeneration and myelination in secondary progressive multiple sclerosis: Gray matter atrophy and magnetization transfer ratio analyses from the EXPAND phase 3 trial.
Arnold DL, Piani-Meier D, Bar-Or A, Benedict RH, Cree BA, Giovannoni G, Gold R, Vermersch P, Arnould S, Dahlke F, Hach T, Ritter S, Karlsson G, Kappos L, Fox RJ; EXPAND Clinical Investigators. Arnold DL, et al. Among authors: piani meier d. Mult Scler. 2022 Sep;28(10):1526-1540. doi: 10.1177/13524585221076717. Epub 2022 Mar 9. Mult Scler. 2022. PMID: 35261318 Free PMC article. Clinical Trial.
15 results